IPN, Delhi, India. Open 10-6pm

+91 9891296838 / 9811747774

TRYNGOLZA (olezarsen) injection

TRYNGOLZA (olezarsen) injection

Brand: TRYNGOLZA. API: olezarsen is used to treat Familial Chylomicronemia Syndrome (FCS), Severe Hypertriglyceridemia (sHTG).

Tryngolza (olezarsen) is a monthly prescription injection used alongside a low-fat diet to lower dangerously high triglyceride levels (fats in the blood) in adults

Brand Name: TRYNGOLZA – On Request
Generic Name: olezarsen injection
Strength: Injection: 80 mg/0.8 mL in a single-dose autoinjector.
Manufacturer: Ionis Pharmaceuticals Inc.
Approved By: EMA, USFDA
Get access to medicines: In India
Price: On Request

See full prescribing information for TRYNGOLZA : Patient Information

Get access TRYNGOLZA to treat Familial Chylomicronemia Syndrome (FCS), Severe Hypertriglyceridemia (sHTG) on a Named Patient Import Basis

IPN, New Delhi serves as a facilitator for the procurement of specialized drugs on behalf of patients or treating doctors, enabling access to TRYNGOLZA (olezarsen) for personal use. To proceed, the applicant must submit an application in Form 12A along with a valid prescription issued by a Registered Medical Practitioner (RMP).

For any queries, including information regarding the cost of the pharmaceutical product in India, please contact the IPN Healthcare Support Team via email or at the following numbers: Mobile/WhatsApp: Mr. Tarun: +91 9891 296 838 |  Mr. Neeraj: +91 9811 747 774.

Category:

Contact Info

CORPORATE OFFICE:

Basement-B-5-A, Ajit Singh House Building No.12, Yusuf Sarai, South Delhi,
New Delhi:110016 India.

MOBILE / PHONE NUMBER:

M: +91 9811747774, 9891296838.
P / F: +91-11-26532129 / 26536398

EMAIL ID:

info@indianpharmanetwork.co.in

    Olezarsen, sold under the brand name Tryngolza, is a medication used in the treatment of familial chylomicronemia syndrome. It is given by injection under the skin. Olezarsen is an apolipoprotein C-III-directed antisense oligonucleotide. Olezarsen is an antisense oligonucleotide which inhibits the formation of apolipoprotein C3 (apoC-III), a protein that regulates both triglyceride metabolism and liver clearance of chylomicrons and other triglyceride-rich lipoproteins. By reducing serum apoC-III, olezarsen increases clearance of plasma triglycerides.
    The most common side effects include injection site reactions, low platelet counts, and joint pain.

    TRYNGOLZA (olezarsen) injection, for subcutaneous use Initial U.S. Approval: 2024

    Is TRYNGOLZA (olezarsen) available in India?

    TRYNGOLZA (olezarsen) may be accessed in India through a named-patient import process with a valid doctor’s prescription, and Indian Pharma Network (IPN), New Delhi, assists with compliant sourcing and delivery of specialty medicines subject to regulatory approvals.

    How to get TRYNGOLZA Injection delivered in India?

    Indian Pharma Network (IPN), based in New Delhi, helps patients and healthcare providers with the sourcing and import coordination of specialty medicines in compliance with applicable Indian regulations. Availability, import eligibility, pricing, and delivery timelines may vary and are subject to regulatory approvals and documentation requirements.

    IPN having representation in Delhi, Gurugram, Mumbai, Bengaluru, Kolkata, Chennai, Pune, Ahmedabad, Hyderabad, Chandigarh, Jaipur, and Lucknow.

    Who can help source TRYNGOLZA Injection in India legally?

    Named-patient import facilitator contact details
    Company Name: Indian Pharma Network (IPN)
    Address: 60/4 1st Floor, T&T Building, Indian Oil Complex, Yusuf Sarai, Delhi 110016
    For sourcing and import coordination of specialty medicines, contact:
    Mr. Tarun: +91 9891 296 838
    Mr. Neeraj: +91 9811 747 774
    Email: info@indianpharmanetwork.co.in

    Patients are advised to independently verify the credentials, licensing, and regulatory compliance of any facilitator before proceeding.

    Note:
    We are the facilitator, group of highly qualified healthcare professionals, provide solutions on how to get access of anti cancer medicines not available in India. On the basis of permission in Form 12B (Import permit) from From Ministry of Health, Government of India, IPN, New Delhi procure drugs on behalf of patient. Indian Pharma Network (IPN) serves as a legitimate consultant and facilitator situated in New Delhi, India. With over two decades of industry experience, IPN offers extensive coverage across India.

    Related products

    Indian Pharma Network (IPN), New Delhi. India

    Indian Pharma Network (IPN) is registered organisation in India, having highly qualified healthcare professionals of pharmaceutical Industry. Specialized in Oncology Products. Helped more than 6,000 patients. Registration Number : 07AAFFI2544E1ZO under GST Act.
    Branch Offices in India : New Delhi | Bengaluru | Kolkata | Lucknow | Jaipur | Jodhpur.
    Our Overseas Network UK | Russia | Brazil | Mexico | Germany | France| Italy | Spain | Japan | China| Australia | Brazil | Saudi Arabia | South Africa

    Indian Pharma Network
    60/4 1st Floor, T&T Building, Indian Oil Complex, Yusuf Sarai, Delhi 110016

    Mobile / WhatsApp / Phone
    M: +91 9811747774, 9891296838.
    P: +91-11-26532129 / 26536398

    Free Customer Support
    info@indianpharmanetwork.co.in 
    urgent@indianpharmanetwork.co.in